Mixed infections pose threat to swine industry
Novartis Animal Health released alarming new market
research data showing that, despite the presence of effective drugs such as
Denagard on the market, veterinarians and specialists believe that mixed enteric
and respiratory infections still pose a serious problem to infected herds and to
the swine industry as a whole.
The research, conducted by Novartis Animal Health, shows that nearly
two-thirds (63%) of the 102 specialists surveyed believe that mixed respiratory
and enteric infections cause serious or very serious problems for infected
herds, and 53% believe that mixed infections pose a problem for the entire swine
Additionally, 68% of swine specialists regularly saw these mixed respiratory
and enteric infections, and that this problem is growing in scale.
"It is imperative that all veterinarians are aware of the risk of mixed
infections in herds, and diagnose and treat as early as possible with
appropriate medications that can treat enteric as well as respiratory organisms.
These infections can significantly reduce feed conversion as well as average
daily gain and, if not addressed correctly, can compromise treatment efficacy
and not only prove costly to the producer, but also potentially cost the
industry millions," according to Dr Tim Loula, Swine Vet Center, Minnesota.
Dr Jill Thomson, Scottish Agricultural College (SAC) Veterinary Services,
Edinburgh, UK, noted "While vets are aware of the impact of mixed infections in
swine health, there is a need to increase awareness of the scale of the problem
to ensure affected swine are treated swiftly and effectively with products that
address both enteric and respiratory infections in herds with complex disease
"It is vital to stem this increasing problem and return infected pigs to full
health, minimising the financial impact on the individual producer and the
industry as a whole."
â€¢ Novartis Animal Health
the latest pig news, subscribe here
To comment, login here
Or register to be able to comment.